NODULAR EPIRETINAL MÜLLER CELL GLIOSIS IN THE FOVEA.


Journal

Retinal cases & brief reports
ISSN: 1937-1578
Titre abrégé: Retin Cases Brief Rep
Pays: United States
ID NLM: 101298744

Informations de publication

Date de publication:
01 Nov 2023
Historique:
medline: 1 11 2023
pubmed: 17 8 2022
entrez: 16 8 2022
Statut: ppublish

Résumé

The purpose of this study was to report the findings of a hyperreflective nodular epiretinal gliosis observed with optical coherence tomography presumed to be due to subclinical hyaloidal traction causing Mϋller cell cone gliosis. Retrospective, observational case series. Six eyes of six patients (mean age: 57 years, range 35-81 years) presented with a nodular epiretinal gliosis and had an average follow-up interval of 26 months (range 1-82 months). The mean baseline best-corrected visual acuity was 0.25 ± 0.17 (Snellen equivalent 20/38.3 ± 16.9). Fundus photography demonstrated a yellowish lesion overlying the fovea. Optical coherence tomography imaging revealed a hyperreflective preretinal lesion with a mean vertical length of 267 μ m (range 185-497) and a mean greatest linear diameter of 312 µ m (range 124-640). There was no vitreoretinal abnormality including vitreomacular traction or epiretinal membrane noted in any eye, and two of six eyes displayed a definitive posterior vitreous detachment. These nodules may have occurred before and persisted even after a posterior vitreous detachment or may have been acquired after the posterior vitreous detachment. The nodules typically remained stable with minimal change although in one eye, a posterior vitreous detachment occurred 6 months after initial presentation and lifted the gliosis off of the retinal surface where it remained attached to the posterior hyaloid. Foveal nodular epiretinal gliosis may occur due to subclinical hyaloidal traction on the Müller cell cone even without obvious vitreoretinal interface abnormality on optical coherence tomography.

Identifiants

pubmed: 35972829
doi: 10.1097/ICB.0000000000001298
pii: 01271216-202311000-00032
pmc: PMC10597442
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

779-784

Références

Bringmann A, Unterlauft JD, Barth T, et al. Müller cells and astrocytes in tractional macular disorders. Prog Retin Eye Res 2021;86:100977.
Yamada E Some structural features of the fovea centralis in the human retina. Arch Ophthalmol 1969;82:151–159.
Pang CE, Spaide RF, Freund KB. Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity. Retina 2014;34:1513–1523.
Corvi F, Pellgrini M, Staurenghi G, et al. Nodular epiretinal gliosis in the fovea. Ophthalmol Retina 2021;5:594–596.
Dyer MA, Cepko CI. Control of Muller glial cell prolifeation and activation following retinal injury. Nat Neurosci 2000;3:873–880.
Ozdemir H, Karacorlu M. Epiretinal membrane with foveal herniation. Retina 2017;37:e71–e72.
Durrani AF, Johnson MW. Foveal tuft retina 2021;41:e47–e48.
Scharf JM, Hilely A, Preti RC, et al. Hyperreflective stress lines and macular holes. Invest Ophthalmol Vis Sci 2020;61:50.
Amoroso F, Mrejen S, Pedinielli A, et al. Intrareflective hyperreflective lines. Retina 2021;41:82–92.
Wilson DJ, Green WR. Argo laser panretinal photocoagulation for diabetic retinopathy. Scanning electron microscopy of human choroidal vascular casts. Arch Ophthalmol 1987;105:239–242.
Conedera FM, Pousa AMQ, Mercader N, et al. Retinal microglia signaling affects Müller cell behavior in the zebrafish following laser injury induction. Glia 2019;67: 1150–1166.
Coughlin BA, Feenstra DJ, Mohr S. Müller cells and diabetic retinopathy. Vis Res 2017;139:93–100.

Auteurs

Jesse J Jung (JJ)

East Bay Retina Consultants Inc., Oakland, California.
Department of Ophthalmology, University of California, San Francisco, San Francisco, California.

Anne Zeng (A)

East Bay Retina Consultants Inc., Oakland, California.

Rahul Komati (R)

Department of Ophthalmology & Visual Science, The University of Chicago, Chicago, Illinois.

Anna G Mackin (AG)

Department of Ophthalmology & Visual Science, The University of Chicago, Chicago, Illinois.

Dimitra Skondra (D)

Department of Ophthalmology & Visual Science, The University of Chicago, Chicago, Illinois.

Yoshihiro Yonekawa (Y)

Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PN.

Mitchell S Fineman (MS)

Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PN.

Isaac Ezon (I)

Jersey Shore Retina Consultants, West Long Branch, New Jersey.

Soraya Rofagha (S)

East Bay Retina Consultants Inc., Oakland, California.
Department of Ophthalmology, University of California, San Francisco, San Francisco, California.

Quan V Hoang (QV)

Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, Singapore.
Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore ; and.
Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia College of Physicians and Surgeons, New York, New York .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH